NCT05174403View on ClinicalTrials.gov

Imaging Biomarkers in Spastic Paraplegia Type 5

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

January 28, 2022

Primary Completion Date

July 25, 2023

Study Completion Date

July 25, 2023

Conditions
Spastic Paraplegia Type 5A, Recessive
Interventions
OTHER

Cerebral and spinal cord magnetic resonance imaging

"Cerebral and spinal cord magnetic resonance imaging (without injection of contrast medium).~Patient's data will be compared to calibrated data from the commercially available medical software Brain Quant (licence BT-BQ-001-START, market CAIH, CE12331)."

Trial Locations (1)

Unknown

APHP - Pitié Salpetriere Hospital, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER